Immunization, Hib3 in East Asia & Pacific (IDA & IBRD countries)
East Asia & Pacific (IDA & IBRD countries): Immunization, Hib3 was 40.1% in 2024. ◆ Volatile
Immunization, Hib3 in East Asia & Pacific (IDA & IBRD countries), 1990–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
East Asia & Pacific (IDA & IBRD countries) recorded 40.1% for immunization, hib3 in 2024.
The figure is up 2.3% on the previous year and up 76.6% over ten years.
Over the whole period, immunization, hib3 in East Asia & Pacific (IDA & IBRD countries) peaked at 40.3% in 2022 and was at its lowest, 0.0%, in 1990.
East Asia & Pacific (IDA & IBRD countries) ranks 43rd of 43 groups on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, Hib3 in East Asia & Pacific (IDA & IBRD countries), year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1990 | 0.0% | — |
| 1991 | 0.0% | — |
| 1992 | 0.0% | — |
| 1993 | 0.0% | — |
| 1994 | 0.0% | — |
| 1995 | 0.0% | — |
| 1996 | 0.0% | — |
| 1997 | 0.1% | — |
| 1998 | 0.1% | +3.0% |
| 1999 | 0.1% | +7.6% |
| 2000 | 0.1% | +9.9% |
| 2001 | 0.1% | -1.2% |
| 2002 | 0.1% | +2.9% |
| 2003 | 0.1% | +1.0% |
| 2004 | 1.4% | +1596.0% |
| 2005 | 1.8% | +22.2% |
| 2006 | 1.9% | +6.3% |
| 2007 | 1.9% | +2.5% |
| 2008 | 2.1% | +8.1% |
| 2009 | 2.5% | +20.1% |
| 2010 | 7.2% | +188.9% |
| 2011 | 9.8% | +36.7% |
| 2012 | 16.4% | +66.9% |
| 2013 | 16.7% | +2.2% |
| 2014 | 22.7% | +35.7% |
| 2015 | 31.4% | +38.4% |
| 2016 | 32.3% | +3.0% |
| 2017 | 32.3% | -0.1% |
| 2018 | 29.2% | -9.7% |
| 2019 | 32.5% | +11.5% |
| 2020 | 32.6% | +0.3% |
| 2021 | 31.5% | -3.4% |
| 2022 | 40.3% | +27.9% |
| 2023 | 39.2% | -2.8% |
| 2024 | 40.1% | +2.3% |
Biggest year-on-year movements
Years where Immunization, Hib3 in East Asia & Pacific (IDA & IBRD countries) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2004 | +1596.0% | 0.1% | 1.4% |
| 2010 | +188.9% | 2.5% | 7.2% |
| 2012 | +66.9% | 9.8% | 16.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 0.0% | 0.0% | 0.1% | 10 |
| 2000s | 1.2% | 0.1% | 2.5% | 10 |
| 2010s | 23.0% | 7.2% | 32.5% | 10 |
| 2020s | 36.7% | 31.5% | 40.3% | 5 |
Countries ranked near East Asia & Pacific (IDA & IBRD countries)
More health data for East Asia & Pacific (IDA & IBRD countries)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, annual growth rate -0.843 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0369 units per person (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, annual growth rate -4.17 % change on previous year (2025)
- Population ages 40-44, male, annual growth rate 2.03 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0353 units per person (2025)
- Population ages 35-39, female, per capita 0.0397 units per person (2025)
Frequently asked questions
- What is immunization, hib3 in East Asia & Pacific (IDA & IBRD countries)?
- Immunization, hib3 in East Asia & Pacific (IDA & IBRD countries) was 40.1% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in East Asia & Pacific (IDA & IBRD countries)?
- The highest recorded value was 40.3% in 2022.
- What is the lowest immunization, hib3 recorded in East Asia & Pacific (IDA & IBRD countries)?
- The lowest recorded value was 0.0% in 1990.
- How does East Asia & Pacific (IDA & IBRD countries) rank for immunization, hib3?
- East Asia & Pacific (IDA & IBRD countries) ranks 43rd out of 43 groups with data for 2024.
- Is immunization, hib3 rising or falling in East Asia & Pacific (IDA & IBRD countries)?
- Over the last ten years it is up 76.6%. The long-run trend across the full record is volatile.
- Where does this East Asia & Pacific (IDA & IBRD countries) data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.